Author correction to “Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers” [Acta Pharmaceutica Sinica B 11 (2021) 355–372]

Detalles Bibliográficos
Autores principales: Jiang, Tingting, Wang, Guan, Liu, Yao, Feng, Lu, Wang, Meng, Liu, Jie, Chen, Yi, Ouyang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214051/
https://www.ncbi.nlm.nih.gov/pubmed/35755289
http://dx.doi.org/10.1016/j.apsb.2022.02.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214051/
https://www.ncbi.nlm.nih.gov/pubmed/35755289
http://dx.doi.org/10.1016/j.apsb.2022.02.028

Ejemplares similares